Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.53B P/E - EPS this Y -8.90% Ern Qtrly Grth -
Income -328.07M Forward P/E -8.23 EPS next Y -8.10% 50D Avg Chg 31.00%
Sales 44.58M PEG -0.51 EPS past 5Y - 200D Avg Chg 55.00%
Dividend N/A Price/Book 5.88 EPS next 5Y 12.00% 52W High Chg -21.00%
Recommedations 2.70 Quick Ratio 4.24 Shares Outstanding 227.14M 52W Low Chg 190.00%
Insider Own 5.77% ROA -32.29% Shares Float 187.99M Beta 0.83
Inst Own 92.41% ROE -69.12% Shares Shorted/Prior 43.52M/38.24M Price 13.17
Gross Margin 4.46% Profit Margin - Avg. Volume 5,772,806 Target Price 13.00
Oper. Margin -919.27% Earnings Date May 6 Volume 4,541,377 Change -4.67%
About Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Recursion Pharmaceuticals, Inc. News
03/26/24 Recursion Publishes Annual Environmental, Social and Governance Report
03/22/24 Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares
03/18/24 New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence
03/15/24 Recursion Pharmaceuticals Inc CFO Michael Secora Sells 50,000 Shares
03/11/24 Recursion Announces Plans to Open New Office in London
03/07/24 Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst
03/01/24 Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
03/01/24 Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
03/01/24 Recursion to Participate in Upcoming Investor Conferences
03/01/24 Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates
06:44 PM Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today
10:56 AM Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2023 Earnings Call Transcript
02/27/24 Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue Estimates
02/27/24 Recursion Pharmaceuticals Inc (RXRX) Reports Mixed Financial Results Amidst Advancements in ...
02/27/24 Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
02/24/24 Recursion Pharmaceuticals Inc President and COO Tina Marriott Sells 8,000 Shares
02/22/24 These 2 Healthcare Stocks Are in Nvidia's Portfolio. Should They Be in Yours?
02/20/24 Recursion to Host Public L(earnings) Call on February 27
02/19/24 Double Your Money: 3 Growth Stocks to Grab in 2024
02/19/24 Analysts Estimate Recursion Pharmaceuticals (RXRX) to Report a Decline in Earnings: What to Look Out for
RXRX Chatroom

User Image Didgeman Posted - 50 minutes ago

@TwelveEggsInOneBasket @Chi_Booth if Jamie was more direct, I would believe he actually told him to stop selling. I coached people at Jamie’s level - they should be more direct in my opinion. I guess we shall see but until then the CEO and senior managers of $RXRX need to stop selling there shares and scaring away investors.

User Image stayretired Posted - 1 hour ago

$RXRX short interest 29.7% There is going to be a HUGE squeeze on any good news. Bears are going to hurt.

User Image Galactic_Stock_Savant Posted - 2 hours ago

$AVTX sold moving all profits into $RXRX ai biotech

User Image DailyStocksPicks Posted - 14 hours ago

My Oversold pick #1 for today is $NMRA It's seen as a clinical-stage biopharmaceutical company focusing on brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. Despite reporting significant losses, analysts hold a positive outlook, suggesting a strong potential upside based on its clinical pipeline​​​​. $KYMR, $CGON, $RXRX, $DNA https://youtu.be/7pOcCYEQIxM

User Image jheerdink Posted - 18 hours ago

$LTRN Lantern's AI Platform Growth: Exceeded 2023 goal with 60 billion datapoints, targeting 100 billion by 2024. https://finance.yahoo.com/news/lantern-pharma-inc-reports-progress-213202149.html $RXRX

User Image Didgeman Posted - 19 hours ago

@TwelveEggsInOneBasket Still sucks! Bad design is bad design! How much do they pay you to swat away real deserved criticism? The suck meter is for $RXRX logo is off the charts!

User Image Didgeman Posted - 21 hours ago

$RXRX why does their logo look so “woke rainbow people” really sucks.

User Image Didgeman Posted - 21 hours ago

$RXRX oh, looks like we’re back to $10 again darn it! Yeah… I’m not buying again till under $9. Only way to change my mind is to get the insiders to stop selling their stock. Freaking newbie executives don’t understand the market and the perception of them selling has on the market.

User Image Julianhh Posted - 21 hours ago

$RXRX if Cathie Wood buys a stock you always gotta pay attention

User Image Galactic_Stock_Savant Posted - 22 hours ago

$RXRX waiting for our $GCTS day

User Image TwelveEggsInOneBasket Posted - 22 hours ago

$RXRX maybe that visit from Jamie will taper off those insider sells.

User Image Galactic_Stock_Savant Posted - 23 hours ago

$RXRX this is pretty dope RXRX ceos profile picture on X is him and the $NVDA ceo showing off their tattoos RxRx is an ai biotech company

User Image Galactic_Stock_Savant Posted - 23 hours ago

$RXRX now this is very very interesting…. $JPM CEO meeting with Ai biotech ran on the $NVDA platform

User Image JustTradingHoy Posted - 1 day ago

$RXRX $JPM Jamie Simon himself. Wonder what JPM analyst will rate RXRX when he sees that his boss what at RXRX?

User Image sogenerous Posted - 1 day ago

$ABCL $RXRX wish these 2 could merge - would be very diversified play then

User Image CromieAds Posted - 1 day ago

$ABCL is my AI drug discovery stock for the next 10 years. $RXRX is good as well. Money will be chasing best of breed AI stocks in each category to diversify. I believe I found the best one.

User Image Galactic_Stock_Savant Posted - 1 day ago

$RXRX just chill out, long term this is a gold mine just sit on it

User Image JustTradingHoy Posted - 1 day ago

$RXRX if insiders would not drop shares every week and if ARkk wasn't involved it would be in the $20s already. We have to contend with what we have ☹️

User Image JustTradingHoy Posted - 1 day ago

$RXRX each time ARKk buys some deep pockets come and shorts whatever Cathy Wood buys.

User Image Galactic_Stock_Savant Posted - 1 day ago

$NVDA closed my short at 895 for a 250% gain , thanks quick 59,000 first ever short attempt after being a perma bull Moving it all into $rxrx long Ai biotech , yes pleeeaaase

User Image Whyaskwhy Posted - 1 day ago

$RXRX added

User Image JBResearch Posted - 1 day ago

@JustTradingHoy $XBI $RXRX Cathy Wood has known better days... https://posts.voronoiapp.com/markets/These-Funds-Wiped-Out-the-Most-Wealth-Over-the-Past-Decade--855

User Image Etrading Posted - 1 day ago

$MRK today news might fud the bears in biotech $gild $bmy $rxrx etc.. $spy

User Image tickertutor Posted - 1 day ago

$IBIO So just for context, this is how much other AI drug discovery platform cos are being valued here… $SDGR 1.85B, $RXRX 2.4B, $EXAI 725M $ABSI 600M. No suggestion here… just context.

User Image jaydilks Posted - 1 day ago

$RXRX $JPM https://x.com/recursionchris/status/1772958321084960819?s=61&t=kw_xII2XZ5e1QHzmVVzmLQ

User Image TraderJackson_ Posted - 1 day ago

$WISH $QNRX $RXRX $RBLX BREAKING OUT 🐺

User Image JustTradingHoy Posted - 1 day ago

$RXRX ARK bought 600K + plus in one fund and 120K + in the other. It looks like its largest (in share quantity) purchase for March 26.

User Image JustTradingHoy Posted - 1 day ago

$RXRX lastest daily buys and sells... https://twitter.com/ArkkDaily/status/1772776713249751045?t=5FrBdmb0bYWhcbZzYIjT9A&s=19

User Image Galactic_Stock_Savant Posted - 1 day ago

$RXRX nvidia is cool but why wouldn’t you want the 2b dollar company that’s making the ai drug testing model for them Should be worth 10 billion at least and that’s still cheap at that market cap the stock would be 50 a share Low float could potentially be worth hundreds in 1-2 years $spy $nvda $SMCI

User Image Galactic_Stock_Savant Posted - 1 day ago

$RXRX this looks like a 25-50$ stock in the short term long term heck this could pull a smci

Analyst Ratings
Keybanc Overweight Mar 4, 24
Needham Buy Feb 28, 24
TD Cowen Market Perform Jan 26, 24
Needham Buy Jan 17, 24
Needham Buy Jan 16, 24
JP Morgan Neutral Nov 13, 23
Needham Buy Nov 9, 23
Needham Buy Sep 5, 23
Needham Buy Aug 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Larson Tina Marriott President and COO President and COO Jan 25 Sell 10.35 8,000 82,800 414,548 01/29/24
Larson Tina Marriott President and COO President and COO Jan 25 Option 1.06 8,000 8,480 422,584 01/29/24
Borgeson Blake Director Director Jan 23 Sell 10.5756 20,054 212,083 7,324,364 01/25/24
Virani Shafique Chief Business Offic.. Chief Business Officer Jan 16 Sell 10.93 18,000 196,740 136,748 01/18/24
Virani Shafique Chief Business Offic.. Chief Business Officer Jan 16 Option 2.22 18,000 39,960 154,748 01/18/24
Secora Michael Chief Financial Offi.. Chief Financial Officer Jan 16 Sell 10.35 50,000 517,500 981,014 01/18/24
Secora Michael Chief Financial Offi.. Chief Financial Officer Jan 16 Option 2.22 75,000 166,500 1,006,014 01/18/24
Li Dean Y Director Director Jan 09 Sell 13.84 29,000 401,360 421,000 01/11/24
Borgeson Blake Director Director Jan 09 Sell 13.51 20,054 270,930 7,344,418 01/11/24
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Jan 03 Sell 9.5 55,853 530,604 01/05/24
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Jan 03 Option 2.48 31,250 77,500 822,578 01/05/24
Larson Tina Marriott President and COO President and COO Dec 28 Option 1.06 8,000 8,480 422,548 01/02/24
Larson Tina Marriott President and COO President and COO Dec 28 Sell 10.58 8,000 84,640 414,548 01/02/24
Borgeson Blake Director Director Dec 26 Sell 10.6285 20,054 213,144 7,364,472 12/28/23
Virani Shafique Chief Business Offic.. Chief Business Officer Dec 15 Sell 9.6 18,000 172,800 136,748 12/19/23
Virani Shafique Chief Business Offic.. Chief Business Officer Dec 15 Option 2.22 18,000 39,960 154,748 12/19/23
Dar Zavain Director Director Dec 14 Sell 9.00 20,141 181,269 53,823 12/18/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Dec 12 Sell 7.49 50,000 374,500 956,014 12/14/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Dec 12 Option 2.22 75,000 166,500 981,014 12/14/23
Borgeson Blake Director Director Dec 12 Sell 7.3987 11,447 84,693 7,384,526 12/14/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Dec 06 Sell 7.49 59,829 448,119 791,328 12/08/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Dec 06 Option 2.48 31,250 77,500 851,157 12/08/23
Borgeson Blake Director Director Nov 28 Sell 6.7195 11,447 76,918 7,395,973 11/30/23
Larson Tina Marriott President and COO President and COO Nov 15 Sell 6.76 3,000 20,280 413,404 11/17/23
Larson Tina Marriott President and COO President and COO Nov 15 Option 1.06 3,000 3,180 416,404 11/17/23
Virani Shafique Chief Business Offic.. Chief Business Officer Nov 15 Sell 6.51 18,000 117,180 140,351 11/17/23
Virani Shafique Chief Business Offic.. Chief Business Officer Nov 15 Option 2.22 18,000 39,960 158,351 11/17/23
Borgeson Blake Director Director Nov 14 Sell 6.3197 8,885 56,151 7,407,420 11/16/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Nov 14 Sell 7.06 50,000 353,000 938,186 11/16/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Nov 14 Option 2.22 75,000 166,500 963,186 11/16/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Nov 01 Sell 5.15 62,177 320,212 11/03/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Nov 01 Option 2.48 31,250 77,500 873,997 11/03/23
Borgeson Blake Director Director Oct 31 Sell 5.2745 8,885 46,864 7,416,305 11/02/23
Larson Tina Marriott President and COO President and COO Oct 26 Sell 5.63 3,000 16,890 418,782 10/30/23
Larson Tina Marriott President and COO President and COO Oct 26 Option 1.06 3,000 3,180 421,782 10/30/23
Borgeson Blake Director Director Oct 17 Sell 6.5822 8,885 58,483 7,425,190 10/19/23
Virani Shafique Chief Business Offic.. Chief Business Officer Oct 16 Sell 6.3 18,000 113,400 140,351 10/18/23
Virani Shafique Chief Business Offic.. Chief Business Officer Oct 16 Option 2.22 18,000 39,960 158,351 10/18/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Oct 10 Sell 6.96 50,000 348,000 913,186 10/12/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Oct 10 Option 2.22 75,000 166,500 938,186 10/12/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Oct 04 Sell 7.21 59,794 431,115 842,747 10/06/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Oct 04 Option 2.48 31,250 77,500 902,541 10/06/23
Borgeson Blake Director Director Oct 03 Sell 7.2907 8,885 64,778 7,434,075 10/05/23
Larson Tina Marriott President and COO President and COO Sep 28 Sell 7.72 3,000 23,160 418,782 10/02/23
Larson Tina Marriott President and COO President and COO Sep 28 Option 1.06 3,000 3,180 421,782 10/02/23
Borgeson Blake Director Director Sep 19 Sell 8.3599 8,885 74,278 7,442,960 09/21/23
Virani Shafique Chief Business Offic.. Chief Business Officer Sep 15 Sell 8.66 18,000 155,880 140,351 09/19/23
Virani Shafique Chief Business Offic.. Chief Business Officer Sep 15 Option 2.22 18,000 39,960 158,351 09/19/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Sep 12 Sell 8.56 50,000 428,000 888,186 09/14/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Sep 12 Option 2.22 75,000 166,500 913,186 09/14/23